Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 2
1998 1
2000 1
2001 1
2003 1
2004 2
2005 1
2006 3
2008 5
2009 5
2010 3
2011 4
2012 6
2013 11
2014 10
2015 11
2016 11
2017 16
2018 9
2019 17
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 30139841

110 results
Results by year
Filters applied: . Clear all
Page 1
Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.
El-Jawahri A, Nelson-Lowe M, VanDusen H, Traeger L, Abel GA, Greer JA, Fathi A, Steensma DP, LeBlanc TW, Li Z, DeAngelo D, Wadleigh M, Hobbs G, Foster J, Brunner A, Amrein P, Stone RM, Temel JS. El-Jawahri A, et al. Oncologist. 2019 Feb;24(2):247-254. doi: 10.1634/theoncologist.2018-0317. Epub 2018 Aug 23. Oncologist. 2019. PMID: 30139841 Free PMC article.
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.
El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, Fathi A, Steensma DP, LeBlanc TW, Horick NK, DeAngelo DJ, Wadleigh M, Hobbs G, Foster J, Brunner AM, Amrein P, Stone RM, Temel JS, Greer JA. El-Jawahri A, et al. Leukemia. 2019 Oct;33(10):2393-2402. doi: 10.1038/s41375-019-0449-1. Epub 2019 Mar 28. Leukemia. 2019. PMID: 30923318
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, Bories P, Sarry A, Laurent G, Récher C, Lamy S. Berger E, et al. BMC Cancer. 2019 Sep 5;19(1):883. doi: 10.1186/s12885-019-6093-3. BMC Cancer. 2019. PMID: 31488077 Free PMC article. Clinical Trial.
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Gardin C, Chevret S, Pautas C, Turlure P, Raffoux E, Thomas X, Quesnel B, de Revel T, de Botton S, Gachard N, Renneville A, Boissel N, Preudhomme C, Terré C, Fenaux P, Bordessoule D, Celli-Lebras K, Castaigne S, Dombret H. Gardin C, et al. J Clin Oncol. 2013 Jan 20;31(3):321-7. doi: 10.1200/JCO.2011.40.3642. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248249 Clinical Trial.
Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
Booth A, Bell T, Halhol S, Pan S, Welch V, Merinopoulou E, Lambrelli D, Cox A. Booth A, et al. J Med Internet Res. 2019 Nov 22;21(11):e14285. doi: 10.2196/14285. J Med Internet Res. 2019. PMID: 31755871 Free PMC article.
Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
Boddu PC, Kantarjian HM, Ravandi F, Garcia-Manero G, Verstovsek S, Jabbour EJ, Takahashi K, Bhalla K, Konopleva M, DiNardo CD, Ohanian M, Pemmaraju N, Jain N, Pierce S, Wierda WG, Cortes JE, Kadia TM. Boddu PC, et al. Cancer. 2017 Aug 15;123(16):3050-3060. doi: 10.1002/cncr.30704. Epub 2017 Apr 7. Cancer. 2017. PMID: 28387922 Free PMC article.
110 results
Jump to page
Feedback